logo
Gonorrhoea vaccine programme to launch after rise in diagnoses

Gonorrhoea vaccine programme to launch after rise in diagnoses

Sky Newsa day ago

Why you can trust Sky News
A new vaccine programme will be launched in Scotland to help curb cases of gonorrhoea following a rise in diagnoses post-pandemic.
The sexually transmitted infection (STI) is the nation's second most common bacterial STI, with the latest figures showing 5,999 cases in 2023 - a 59% increase since before COVID hit.
It is hoped the £280,000 programme - which will begin in August and is being funded by the Scottish government - will address increasing health inequalities and growing resistance to antibiotics treatment.
Those eligible include gay and bisexual men at highest risk of infection, those involved in selling or exchanging sex regardless of gender, and those who sexual health clinic professionals assess as being at a similar risk level.
Gonorrhoea can cause significant pain and discomfort, and in rare cases life-threatening sepsis.
Public Health Minister Jenni Minto said: "This action is urgent and timely since the number of diagnoses has been high and the disease is becoming increasingly difficult to treat with antibiotics.
"The science tells us that this vaccine will potentially protect thousands of people and prevent the spread of infection.
"Anything which stops people from contracting gonorrhoea in the first place can have huge benefits, including ensuring our health system remains resilient by reducing the amount of treatment needed."
The medication will be delivered by the Scottish Vaccination and Immunisation Programme led by Public Health Scotland (PHS).
The funding is expected to cover first and second doses of the 4CMenB vaccine.
The Scottish government said the vaccine was 30-40% effective and will be offered in clinics alongside those for HPV, hepatitis and the routine mpox vaccination programme.
Dr Sam Ghebrehewet, head of the vaccination and immunisation division at PHS, said: "With gonorrhoea diagnoses having increased in recent years, the offer of the 4CMenB vaccine to those at highest risk of exposure is a welcome new intervention.
"This vaccination programme is expected to help control and prevent the spread of gonorrhoea.
"Public Health Scotland is working with the Scottish government and colleagues across NHS boards to finalise plans for the rollout of this targeted vaccination offering to those at increased risk of gonorrhoea from August 2025."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Millions more at risk of world's most infectious disease after patient visits second-largest Texas county
Millions more at risk of world's most infectious disease after patient visits second-largest Texas county

Daily Mail​

time14 minutes ago

  • Daily Mail​

Millions more at risk of world's most infectious disease after patient visits second-largest Texas county

One of America's largest counties is on red alert after a resident was diagnosed with measles, potentially exposing millions more to the deadly disease. According to Dallas County Health and Human Services in Texas, the patient was a female in her mid-20s who was fully vaccinated but contagious from May 30 until June 7. She is currently a resident of Dallas County, which is the the second-most populous county in Texas and the eighth-most populous in the US, with a population of over 2.6 million people. The infected woman also traveled to the city of Plano, and she visited two businesses. On May 31 between the hours of 9am to noon the infected woman visited Lemma Coffee in the downtown area and the next day, on June 1, she went to the First Baptist church from 1pm to 5:30pm. Health officials said the woman has received care, and they are working to identify and notify individuals who may have been exposed. According to DCHHS, this is an ongoing investigation of an isolated case because the source of the woman's exposure to measles is not known. However, the new case comes as Texas is battling a measles outbreak that has infected nearly 800 people and killed two children. Dallas officials are warning anyone who fears they may have been exposed to contact their health provider and monitor for symptoms in what is the latest in a string of measles scares to rock America's major cities and travel hubs. This is the first case in Dallas County amid a major outbreak across Texas. At this time, 744 cases have been confirmed in the state since late January. Ninety-six of the patients have been hospitalized and there have been two fatalities in unvaccinated school-aged children who lived in the outbreak area. Overall, in the US there have been 1,168 confirmed measles cases reported by 34 states and at least three deaths. Measles is the world's most contagious disease - infecting nine out of 10 people exposed - but those who are fully vaccinated are protected in 97 percent of cases. The illness causes tiny white spots inside the mouth, flat red spots on the neck, torso, arms, legs, and feet, ear infections and a high fever. If severe, it can lead to life-threatening pneumonia. Children need two doses of the measles, mumps, rubella (MMR) vaccine: the first at age 12-15 months, and the second dose at age 4-6 years. Babies ages 6-11 months should get an early dose if traveling internationally. Adults should also check to see if they are immune to measles. About one to three in 1,000 people with measles dies of the illness. In an updated advisory, the CDC is warning that people can get infected with measles during travel or at crowded events, unless they are fully vaccinated or have had the disease. The notice reads: 'Travelers can catch measles in many travel settings, including travel hubs like airports and train stations, on public transportation like airplanes and trains, at tourist attractions, and at large, crowded events. 'Infected travelers can bring the disease back to their home communities where it can spread rapidly among people who are not immune.' The government agency recommends that all travelers be fully vaccinated against measles before traveling to an international destination. The last time measles was this rife in the US was in 2019, when there were 1,274 cases reported for the entire year. Measles was officially eradicated in the US in 2000 amid a successful vaccination campaign. At the time, the CDC described achieving measles elimination status in the US as a 'historic public health achievement'. However, a recent study found uptake of the vaccine among children declined in eight in 10 US counties last year, which is being signaled as the cause of the measles resurgence. Overall, vaccine rates fell three percent across the country. It means that 91 percent of children are vaccinated against measles, which is below the 95 percent needed to prevent the disease from spreading and causing deaths. The Johns Hopkins University researchers warned that if vaccination rates continue to fall, measles is likely to return and become a common infection among Americans.

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Reuters

time2 hours ago

  • Reuters

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

June 13 (Reuters) - Moderna's shares (MRNA.O), opens new tab fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The RSV shot, mRESVIA, secured U.S. approval on Thursday for expanded use in at-risk adults aged 18 to 59 years, but needs the U.S. Centers for Disease Control and Prevention's recommendation before it is made available for the age group. It is already approved for use in adults aged 60 or older. The biotech's stock extended its decline into the second session, following the appointment of the new panel late Wednesday. Some of the new appointees have openly expressed anti-vaccine views, including against the mRNA vaccine technology on which Moderna's shots are based. Earlier this week, Health Secretary Robert F. Kennedy Jr. fired all 17 members of the panel, known as the Advisory Committee on Immunization Practices (ACIP), saying it would "re-establish public confidence in vaccine science" - a move health experts warn could undermine public confidence in available vaccines. The ACIP advises the CDC on who should get the shots after they are approved by the U.S. Food and Drug Administration. The panel meeting for Moderna's RSV shot, scheduled for later this month, will be the "first time for investors to see the refreshed ACIP in action and will be important for sentiment in the vaccine sector, which continues to decline in our view," said William Blair analyst Myles Minter. U.S.-listed shares of GSK (GSK.L), opens new tab and Pfizer (PFE.N), opens new tab fell marginally and those of smaller Novavax (NVAX.O), opens new tab were down 1.7% at $7.03 in premarket trade. The CDC currently recommends Moderna's vaccine for adults aged 75 and older, as well as for at-risk adults aged 60 to 74. In April, the ACIP recommended the use of approved RSV vaccines in at-risk adults aged 50 to 59. However, the CDC is yet to sign off on the recommendation.

Poo transplant: 'Poo pills' and the fight against superbugs
Poo transplant: 'Poo pills' and the fight against superbugs

BBC News

time4 hours ago

  • BBC News

Poo transplant: 'Poo pills' and the fight against superbugs

You might think of it as just some stinky brown waste but scientists are finding lots of useful ways to use human latest is in the fight against superbug infections - infections that don't respond to antibiotics - using pills filled with freeze-dried faeces. The idea is that stool samples packed with good bacteria from healthy people are put into a pill, taken by someone with a superbug infection and the healthy bacteria will help to flush out the to the UK Health Security Agency, antibiotic resistant infections are on the rise but Dr Blair Merrick who tested the pills says: "We could potentially, in the future, replace antibiotics with microbiome [therapies] - that's the big picture, so there's a lot of potential." Why are superbugs a problem? Humans have been using antibiotics to treat infections for nearly 100 years. But as taking them became more common in recent years, sometimes in situations where they weren't needed, some strains of bacteria have developed a resistance to types of antibiotics. It means they can be difficult to treat and life-threatening. According to the NHS, the biggest worry is that new strains of bacteria will eventually also become resistant to antibiotics. How does a poo transplant work? Poo samples from healthy donors are tested to make sure there are no harmful bugs and undigested food is removed before it's freeze dried into a powder. That's then put into a pill which dissolves in the bowel to released the poopy powder. The study, which was carried out at Guy's and St Thomas' hospitals in London, suggests the superbugs are flushed out of the bowel and replaced by healthy gut bacteria. Poo transplants like this aren't a new thing. They've already been successfully used in treating Clostridium difficile (C. diff) which is a type of bacteria that can cause diarrhoea, stomach ache, loss of appetite and it can also make a person feel are also looking at poo transplants as a treatment for liver disease.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store